Marc Grasso
2018
In 2018, Marc Grasso earned a total compensation of $3.6M as Chief Financial Officer, Chief Business Officer and Secretary at Kura Oncology.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Non-Equity Incentive Plan | $69,426 |
| Option Awards | $3,288,000 |
| Salary | $136,876 |
| Other | $39,965 |
| Total | $3,634,267 |
Grasso received $3.3M in option awards, accounting for 90% of the total pay in 2018.
Grasso also received $100K in bonus, $69.4K in non-equity incentive plan, $136.9K in salary and $40K in other compensation.
Rankings
In 2018, Marc Grasso's compensation ranked 3,118th out of 14,244 executives tracked by ExecPay. In other words, Grasso earned more than 78.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,118 out of 14,244 | 78th |
Division Manufacturing | 1,157 out of 5,759 | 80th |
Major group Chemicals And Allied Products | 402 out of 2,122 | 81st |
Industry group Drugs | 331 out of 1,811 | 82nd |
Industry Pharmaceutical Preparations | 254 out of 1,385 | 82nd |
Source: SEC filing on April 29, 2019.
Grasso's colleagues
We found three more compensation records of executives who worked with Marc Grasso at Kura Oncology in 2018.